FDA and Merck Vioxx Probe by House Energy and Commerce Committee
496967
The House Energy and Commerce Committee is investigating how Vioxx was approved and then taken off the market. It has written to Lester Crawford, FDA, and Ray Gilmartin, CEO of Merck, requesting documents about Vioxx.
743520
A top Republican lawmaker raised  concerns about the U.S. Food and Drug Administration's ability  to monitor drug safety following Merck & Co. Inc.'s recall of  its arthritis drug last week, according to a letter made public  on Tuesday.
323949
Pharmaceutical giant Merck &amp; Co Inc. had evidence by 2000 that its painkiller Vioxx, which was pulled off the market on Sept. 30, was not safe, a heart specialist told CBS News program &quot;60 Minutes&quot; on Sunday.
184939
U.S. Food and Drug Administration  Acting Commissioner Lester Crawford on Friday agreed to meet  with a top Republican lawmaker about the agency's handling of  safety concerns over Merck & Co Inc.'s now-withdrawn painkiller  Vioxx.
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent
7830
The U.S. Food and Drug  Administration failed the public in its oversight of Merck & Co  Inc.'s painkiller Vioxx, which has been withdrawn, and is  "incapable of protecting America" from another dangerous drug,  an agency researcher told Congress on Thursday.
242627
U.S. Food and Drug Administration  officials pressured an agency safety official to keep quiet or  water down his findings that the now-withdrawn arthritis drug  Vioxx was dangerous to the heart, a leading Senate Republican  charged on Thursday.
596898
Two US regulators defended the Food and Drug Administration's handling of the withdrawn painkiller Vioxx, disputing the contention of heart researcher Dr. Eric Topol that the agency could have forced Merck &amp; Co. to do more safety testing.
416045
Merck & Co Inc. is evaluating why  its withdrawn painkiller Vioxx raises the chance of heart  attack and stroke, but it has not found a mechanism of action,  a company official said on Monday.
268022
A House of Representatives  subcommittee is expected to take up legislation next week meant  to bolster the Food and Drug Administration&#39;s ability to  monitor prescription drug side effects, the panel&#39;s chairman  said in a letter released on Thursday.
487212
Republican lawmakers on Thursday  charged the U.S. Food and Drug Administration with hindering a  congressional probe into whether the agency suppressed a  possible link between antidepressant use and suicidal behavior  in youth.
75672
WASHINGTON - US Rep. Joe Barton, chairman of the House Energy and Commerce Committee, today asked the Department of Health and Human Services (HHS), Food and Drug Administration (FDA) and Chiron Corporation
365737
The safety of Merck&#39;s (MRK:NYSE - news - research) Vioxx has been questioned again with the posting of an internal Food and Drug Administration study on the agency&#39;s website.
721591
Merck &amp; Co., Inc., knew of problems with its blockbuster painkiller Vioxx long before the drug was pulled from the market in September due to newer studies that linked the medication to an increased risk of heart attack and stroke, the Wall Street Journal
657250
The directors of Merck, the giant drug maker, have opened an independent investigation into whether the company acted properly regarding Vioxx.
237728
At a hearing before the US Senate Finance Committee, Dr. David Graham testified that the Food and Drug Administration pressured him to alter findings of a study regarding Merck &amp; Co.
147266
BOSTON (CBS.MW) -- Merck &amp; Co. said late Tuesday that it is establishing a committee to review its handling of the controversial withdrawal of its popular painkiller Vioxx from the market.